Developing a pipeline of innovative treatments to address critical gaps in reproductive medicine and women’s health

Axovia Therapeutics is developing the first gene therapy to treat diseases caused by cilia dysfunction.

Vantage Biosciences is an ALSA Ventures company at the forefront of targeting the root cause of vision loss associated with diabetes.

Promatix is an ALSA Group company using multi-omic insights to develop the next generation of cancer therapeutics

Treating chronic inflammatory diseases by modulating the immune status of the perivascular milieu

World leader in IgE drugs with a pipeline of therapies to treat solid cancer tumours

Pipeline of first in class oncology drugs leveraging a proprietary database